TRACON Pharmaceuticals, Inc. (NASDAQ:TCON) Expected to Post FY2025 Earnings of ($0.27) Per Share

TRACON Pharmaceuticals, Inc. (NASDAQ:TCON – Free Report) – Research analysts at HC Wainwright reduced their FY2025 earnings per share estimates for shares of TRACON Pharmaceuticals in a report released on Wednesday, April 3rd. HC Wainwright analyst E. White now expects that the biopharmaceutical company will earn ($0.27) per share for the year, down from their […]

Leave a Reply

Your email address will not be published.

Previous post Gearing Up for Next Year? Celebrate Classic Car Restoration Highlights
Next post Antero Resources (NYSE:AR) PT Lowered to $27.00 at Truist Financial